Stock Events
Stock Events
Features
Business
More
Login
Sign Up
Sign Up
Matinas Biopharma (6LJ0.F) Q4 2025 Earnings
6LJ0.F
10
Nov
Confirmed
Q4 2024
Q2 2025
Q3 2025
Q4 2025
-1
-0.9
-0.79
-0.69
Details
Expected EPS
N/A
Actual EPS
N/A
Surprise EPS
0
Surprise Percent
+NaN%
Description
Matinas Biopharma (6LJ0.F) will report earnings of for Q4 2025 on November 10, 2025.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login